Cargando…
Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
Bladder cancer (BC) is heterogeneous and expresses various cell surface targets. Photoimmunotherapy (PIT) involves monoclonal antibodies (MAbs) conjugated to a photoabsorber (PA), IR Dye 700Dx, and then activated by near infra-red light (NIR) to specifically target tumors. We have demonstrated that...
Autores principales: | Siddiqui, Mohammad R., Railkar, Reema, Sanford, Thomas, Crooks, Daniel R., Eckhaus, Michael A., Haines, Diana, Choyke, Peter L., Kobayashi, Hisataka, Agarwal, Piyush K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375935/ https://www.ncbi.nlm.nih.gov/pubmed/30765854 http://dx.doi.org/10.1038/s41598-019-38575-x |
Ejemplares similares
-
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2018) -
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022) -
Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging
por: Ito, Kimihiro, et al.
Publicado: (2016) -
Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase
Publicado: (1995) -
Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)